Blood markers to predict heart problems from cancer therapy
Part of Blood & lymphatic, Cancer, Heart & circulation clinical trials.
This study looks for early warning signs (biomarkers) of heart damage caused by cancer treatments. It is for people who have had cancer treatment, may have heart issues, or are about to start a treatment that could affect the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been treated for cancer with chemotherapy (pills or IV), immunotherapy, or other cancer therapy
- You have had a heart problem possibly related to your cancer treatment, OR you completed treatment without heart problems at least 2 years ago, OR you are about to start a treatment that may affect the heart
- You understand the study and can sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether doctors can predict heart problems caused by certain cancer treatments. It gathers information from patients before they start treatment to build better risk-checking tools.
This study looks at whether a simple blood test can spot early signs of heart damage from certain breast cancer treatments (anthracycline chemo or anti-HER2 drugs). The goal is to protect your heart while you get the cancer treatment you need.
This trial studies how a blood test marker (TRPC6) may help predict and prevent heart muscle damage and heart failure related to some breast cancer medicines. You may join if you’re starting or have received treatment that can stress the heart, or if you already have signs of treatment-related heart problems.
This study looks at blood samples from people with cancer who are starting immunotherapy. Researchers want to find markers that might predict how well the treatment works and whether it could cause side effects.
This study follows patients receiving a type of chemotherapy called anthracyclines to track how it affects the heart over time. The goal is to learn how to better protect heart health during cancer treatment.
This study looks for markers of cancer in your blood. It may help doctors learn more about your tumor and how to treat it.
Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.